Skip to main content
SpringerLink
Log in

Passgenaue Therapie: Was bekannt ist und was noch erforscht werden muss

Typ-2-Diabetes: Einteilung in Subgruppen vorteilhaft?

Type 2 diabetes: Is categorisation into subgroups an advantage?

  • FB_Seminar
  • Published:
MMW - Fortschritte der Medizin Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1

Created with Biorender

Author information

Authors and Affiliations

  1. Klinik für Endokrinologie und Diabetologie, Med. Fakultät und Universitätsklinikum Düsseldorf, Heinrich-Heine-Universität Düsseldorf, Moorenstr 5, 40225, Düsseldorf, Deutschland

    Robert Wagner

Authors
  1. Robert Wagner
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Robert Wagner.

Ethics declarations

Beratertätigkeit: Eli Lilly, Akcea Therapeutics, Daiichi Sankyo, Sanofi-Aventis und NovoNordisk; Vortragshonorare/Reisestipendien: Boehringer-Ingelheim, Novo Nordisk und Sanofi-Aventis

Supplementary Information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wagner, R. Typ-2-Diabetes: Einteilung in Subgruppen vorteilhaft?. MMW Fortschr Med 166, 68–71 (2024). https://doi.org/10.1007/s15006-024-3638-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15006-024-3638-4

Keywords:

Search

Navigation